Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (z)-4-(3-(2-chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol Acetate
2. Clopenthixol Acetate Ester
3. Clopixol-acuphase
1. 85721-05-7
2. 2-[4-[(3z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethyl Acetate
3. 349s2zhf05
4. Clopenthixol Acetate Ester
5. Clopixol Acuphase
6. Clopixol-acuphase
7. Cisordinol-acutard (tn)
8. Einecs 288-415-5
9. Unii-349s2zhf05
10. Schembl1651216
11. Dtxsid00235032
12. Chebi:135722
13. Zinc30691716
14. (z)-4-(3-(2-chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol Acetate
15. Akos015841102
16. Zuclopenthixol Acetate [mart.]
17. Zuclopenthixol Acetate [who-dd]
18. (z)-4-(3-(2-chloro-9h-thioxanthen-9-ylidene)propyl)piperazine-1-ethyl Acetate
19. D08691
20. Q27256348
21. 4-[3-[(z)-2-chloro-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Acetate
Molecular Weight | 443.0 g/mol |
---|---|
Molecular Formula | C24H27ClN2O2S |
XLogP3 | 4.9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 442.1481770 g/mol |
Monoisotopic Mass | 442.1481770 g/mol |
Topological Polar Surface Area | 58.1 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 608 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Reply
03 Mar 2023
Reply
05 Feb 2020
Reply
27 Oct 2015
ABOUT THIS PAGE
A Zuclopenthixol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zuclopenthixol Acetate, including repackagers and relabelers. The FDA regulates Zuclopenthixol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zuclopenthixol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zuclopenthixol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zuclopenthixol Acetate supplier is an individual or a company that provides Zuclopenthixol Acetate active pharmaceutical ingredient (API) or Zuclopenthixol Acetate finished formulations upon request. The Zuclopenthixol Acetate suppliers may include Zuclopenthixol Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Zuclopenthixol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Zuclopenthixol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zuclopenthixol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zuclopenthixol Acetate GMP manufacturer or Zuclopenthixol Acetate GMP API supplier for your needs.
A Zuclopenthixol Acetate CoA (Certificate of Analysis) is a formal document that attests to Zuclopenthixol Acetate's compliance with Zuclopenthixol Acetate specifications and serves as a tool for batch-level quality control.
Zuclopenthixol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Zuclopenthixol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zuclopenthixol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Zuclopenthixol Acetate EP), Zuclopenthixol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zuclopenthixol Acetate USP).
LOOKING FOR A SUPPLIER?